Semin Respir Crit Care Med 2010; 31(6): 698-705
DOI: 10.1055/s-0030-1269829
© Thieme Medical Publishers

Pleural Effusion in Liver Disease

José Castellote Alonso1
  • 1Hepatología y Unidad de Trasplante Hepático, Servicio de Aparato Digestivo, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain
Further Information

Publication History

Publication Date:
06 January 2011 (online)

ABSTRACT

Hepatic hydrothorax is the paradigmatic pleural effusion in liver cirrhosis. It is defined as a pleural effusion in a patient with portal hypertension and no cardiopulmonary disease. The estimated prevalence of this complication in patients with liver cirrhosis is 5 to 6%. Its pathophysiology involves movement of ascitic fluid from the peritoneal cavity into the pleural space through diaphragmatic defects. Thoracentesis and pleural fluid analysis are necessary for diagnosis. Initial management consists of sodium restriction, diuretics, and therapeutic thoracentesis. A transjugular intrahepatic portosystemic shunt may provide a bridge prior to liver transplantation. Spontaneous bacterial empyema is the infection of a preexisting hydrothorax. The more frequent bacteria involved are Enterobacteriaceae and gram-positive cocci. Antibiotic therapy is the cornerstone of therapy. This article reviews etiology, clinical manifestations, and therapy of these two complications of liver cirrhosis and portal hypertension.

REFERENCES

  • 1 Alberts W M, Salem A J, Solomon D A, Boyce G. Hepatic hydrothorax. Cause and management.  Arch Intern Med. 1991;  151 2383-2388
  • 2 Lazaridis K N, Frank J W, Krowka M J, Kamath P S. Hepatic hydrothorax: pathogenesis, diagnosis, and management.  Am J Med. 1999;  107 262-267
  • 3 Garcia Jr N, Mihas A A. Hepatic hydrothorax: pathophysiology, diagnosis, and management.  J Clin Gastroenterol. 2004;  38 52-58
  • 4 Xiol X, Castellote J, Baliellas C et al.. Spontaneous bacterial empyema in cirrhotic patients: analysis of eleven cases.  Hepatology. 1990;  11 365-370
  • 5 Xiol X, Castellví J M, Guardiola J et al.. Spontaneous bacterial empyema in cirrhotic patients: a prospective study.  Hepatology. 1996;  23 719-723
  • 6 Leuallen E C, Carr D T. Pleural effusion; a statistical study of 436 patients.  N Engl J Med. 1955;  252 79-83
  • 7 Light R W, Macgregor M I, Luchsinger P C, Ball Jr W C. Pleural effusions: the diagnostic separation of transudates and exudates.  Ann Intern Med. 1972;  77 507-513
  • 8 Romero S, Candela A, Martín C, Hernández L, Trigo C, Gil J. Evaluation of different criteria for the separation of pleural transudates from exudates.  Chest. 1993;  104 399-404
  • 9 Chen T A, Lo G H, Lai K H. Risk factors for spontaneous bacterial empyema in cirrhotic patients with hydrothorax.  J Chin Med Assoc. 2003;  66 579-586
  • 10 Johnston R F, Loo R V. Hepatic hydrothorax. Studies to determine the source of the fluid and report of thirteen cases.  Ann Intern Med. 1964;  61 385-401
  • 11 Lieberman F L, Peters R L. Cirrhotic hydrothorax: further evidence that an acquired diaphragmatic defect is at fault.  Arch Intern Med. 1970;  125 114-117
  • 12 Esteve M, Xiol X, Fernádez F, Gonzalez F, Baliellas C. Treatment and outcome of hydrothorax in liver cirrhosis.  J Clin Nutr Gastroenterol. 1986;  1 139-144
  • 13 Giacobbe A, Facciorusso D, Barbano F, Andriulli A, Frusciante V. Hepatic hydrothorax: diagnosis and management.  Clin Nucl Med. 1996;  21 56-60
  • 14 Jeffries M A, Kazanjian S, Wilson M, Punch J, Fontana R J. Transjugular intrahepatic portosystemic shunts and liver transplantation in patients with refractory hepatic hydrothorax.  Liver Transpl Surg. 1998;  4 416-423
  • 15 Siegerstetter V, Deibert P, Ochs A, Olschewski M, Blum H E, Rössle M. Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients.  Eur J Gastroenterol Hepatol. 2001;  13 529-534
  • 16 Xiol X, Castellote J, Cortés-Beut R, Delgado M, Guardiola J, Sesé E. Usefulness and complications of thoracentesis in cirrhotic patients.  Am J Med. 2001;  111 67-69
  • 17 Castellote J, Xiol X. Hepatic hydrothorax. In: Light RW, Lee YCG, eds. Textbook of Pleural Diseases. 2nd ed. London: Arnold; 2008: 402-409
  • 18 Strauss R M, Boyer T D. Hepatic hydrothorax.  Semin Liver Dis. 1997;  17 227-232
  • 19 Huang P M, Chang Y L, Yang C Y, Lee Y C. The morphology of diaphragmatic defects in hepatic hydrothorax: thoracoscopic finding.  J Thorac Cardiovasc Surg. 2005;  130 141-145
  • 20 Kakizaki S, Katakai K, Yoshinaga T et al.. Hepatic hydrothorax in the absence of ascites.  Liver. 1998;  18 216-220
  • 21 Castellote J, Gornals J, López C, Xiol X. Acute tension hydrothorax: a life-threatening complication of cirrhosis.  J Clin Gastroenterol. 2002;  34 588-589
  • 22 Xiol X, Castellote J, Cortés-Beut R, Delgado M, Guardiola J, Sesé E. Usefulness and complications of thoracentesis in cirrhotic patients.  Am J Med. 2001;  111 67-69
  • 23 Castellote J, Xiol X, Cortés-Beut R, Tremosa G, Rodríguez E, Vázquez S. [Complications of thoracentesis in cirrhotic patients with pleural effusion].  Rev Esp Enferm Dig. 2001;  93 566-570
  • 24 McVay P A, Toy PTC. Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities.  Transfusion. 1991;  31 164-171
  • 25 Mirouze D, Juttner H U, Reynolds T B. Left pleural effusion in patients with chronic liver disease and ascites: prospective study of 22 cases.  Dig Dis Sci. 1981;  26 984-988
  • 26 Sahn S A. State of the art: the pleura.  Am Rev Respir Dis. 1988;  138 184-234
  • 27 Sesé E, Xiol X, Castellote J, Rodríguez-Fariñas E, Tremosa G. Low complement levels and opsonic activity in hepatic hydrothorax: its relationship with spontaneous bacterial empyema.  J Clin Gastroenterol. 2003;  36 75-77
  • 28 Light R W. Diagnostic principles in pleural disease.  Eur Respir J. 1997;  10 476-481
  • 29 Romero-Candeira S, Fernández C, Martín C, Sánchez-Paya J, Hernández L. Influence of diuretics on the concentration of proteins and other components of pleural transudates in patients with heart failure.  Am J Med. 2001;  110 681-686
  • 30 Tremosa G, Xiol X, Rodríguez E, Castellote J, Lopez C, Gornals J B. Valor del gradiente de albúmina en el diagnóstico diferencial de los derrames pleurales asociados a cirrosis hepática.  [abstract] Gastroenterol Hepatol. 2002;  25 135
  • 31 Romero-Candeira S, Hernández L. The separation of transudates and exudates with particular reference to the protein gradient.  Curr Opin Pulm Med. 2004;  10 294-298
  • 32 Zenda T, Miyamoto S, Murata S, Mabuchi H. Detection of diaphragmatic defect as the cause of severe hepatic hydrothorax with magnetic resonance imaging.  Am J Gastroenterol. 1998;  93 2288-2289
  • 33 Runyon B A. Paracentesis of ascitic fluid: a safe procedure.  Arch Intern Med. 1986;  146 2259-2261
  • 34 Xiol X, Castellote J, Cortés-Beut R, Delgado M, Guardiola J, Sesé E. Usefulness and complications of thoracentesis in cirrhotic patients.  Am J Med. 2001;  111 67-69
  • 35 Runyon B A, Greenblatt M, Ming R H. Hepatic hydrothorax is a relative contraindication to chest tube insertion.  Am J Gastroenterol. 1986;  81 566-567
  • 36 Orman E S, Lok A S. Outcomes of patients with chest tube insertion for hepatic hydrothorax.  Hepatol Int. 2009;  3 582-586
  • 37 Liu L U, Haddadin H A, Bodian C A et al.. Outcome analysis of cirrhotic patients undergoing chest tube placement.  Chest. 2004;  126 142-148
  • 38 Ibrisim D, Cakaloglu Y, Akyuz F et al.. Treatment of hepatic hydrothorax with terlipressin in a cirrhotic patient.  Scand J Gastroenterol. 2006;  41 862-865
  • 39 Murthy S C, Okereke I, Mason D P, Rice T W. A simple solution for complicated pleural effusions.  J Thorac Oncol. 2006;  1 697-700
  • 40 Schneider T, Reimer P, Storz K et al.. Recurrent pleural effusion: who benefits from a tunneled pleural catheter?.  Thorac Cardiovasc Surg. 2009;  57 42-46
  • 41 Mercky P, Sakr L, Heyries L, Lagrange X, Sahel J, Dutau H. Use of a tunnelled pleural catheter for the management of refractory hepatic hydrothorax: a new therapeutic option.  Respiration. 2010;  80 348-352 DOI: 10.1159/000282493
  • 42 Cerfolio R J, Bryant A S. Efficacy of video-assisted thoracoscopic surgery with talc pleurodesis for porous diaphragm syndrome in patients with refractory hepatic hydrothorax.  Ann Thorac Surg. 2006;  82 457-459
  • 43 Assouad J, Barthes FleP, Shaker W, Souilamas R, Riquet M. Recurrent pleural effusion complicating liver cirrhosis.  Ann Thorac Surg. 2003;  75 986-989
  • 44 Drohuin F, Fischer D, Law Koune JD, Boiteau R, Tenaillon A, Labayle D. [Treatment of hydrothorax in liver cirrhosis with chemical pleurodesis associated with continuous positive airway pressure ventilation. Preliminary results].  Gastroenterol Clin Biol. 1991;  15 271-272
  • 45 Northup P G, Harmon R C, Pruett T L, Schenk III W G, Daniel T M, Berg C L. Mechanical pleurodesis aided by peritoneal drainage: procedure for hepatic hydrothorax.  Ann Thorac Surg. 2009;  87 245-250
  • 46 Mouroux J, Perrin C, Venissac N, Blaive B, Richelme H. Management of pleural effusion of cirrhotic origin.  Chest. 1996;  109 1093-1096
  • 47 Milanez de Campos J R, Filho L O, de Campos Werebe E et al.. Thoracoscopy and talc poudrage in the management of hepatic hydrothorax.  Chest. 2000;  118 13-17
  • 48 Kirsch C M. Cirrhotic hydrothorax and the “Law of unintended consequences”.  Chest. 2000;  118 2-4
  • 49 Huang P M, Kuo S W, Lee J M. Thoracoscopic diaphragmatic repair for refractory hepatic hydrothorax: application of pleural flap and mesh onlay reinforcement.  Thorac Cardiovasc Surg. 2006;  54 47-50
  • 50 Rössle M, Siegerstetter V, Huber M, Ochs A. The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of the art.  Liver. 1998;  18 73-89
  • 51 Chalasani N, Clark W S, Martin L G et al.. Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting.  Gastroenterology. 2000;  118 138-144
  • 52 Spencer E B, Cohen D T, Darcy M D. Safety and efficacy of transjugular intrahepatic portosystemic shunt creation for the treatment of hepatic hydrothorax.  J Vasc Interv Radiol. 2002;  13 385-390
  • 53 Strauss R M, Martin L G, Kaufman S L, Boyer T D. Transjugular intrahepatic portal systemic shunt for the management of symptomatic cirrhotic hydrothorax.  Am J Gastroenterol. 1994;  89 1520-1522
  • 54 Gordon F D, Anastopoulos H T, Crenshaw W et al.. The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt.  Hepatology. 1997;  25 1366-1369
  • 55 Wilputte J Y, Goffette P, Zech F, Godoy-Gepert A, Geubel A. The outcome after transjugular intrahepatic portosystemic shunt (TIPS) for hepatic hydrothorax is closely related to liver dysfunction: a long-term study in 28 patients.  Acta Gastroenterol Belg. 2007;  70 6-10
  • 56 Dhanasekaran R, West J K, Gonzales P C et al.. Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis.  Am J Gastroenterol. 2010;  105 635-641
  • 57 Rössle M, Gerbes A L. TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update.  Gut. 2010;  59 988-1000
  • 58 Salerno F, Merli M, Cazzaniga M et al.. MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt.  J Hepatol. 2002;  36 494-500
  • 59 Xiol X, Tremosa G, Castellote J et al.. Liver transplantation in patients with hepatic hydrothorax.  Transpl Int. 2005;  18 672-675
  • 60 Sersté T, Moreno C, Francoz C et al.. The impact of preoperative hepatic hydrothorax on the outcome of adult liver transplantation.  Eur J Gastroenterol Hepatol. 2010;  22 207-212
  • 61 Castellote J, Lopez C, Gornals J, Domingo A, Xiol X. Use of reagent strips for the rapid diagnosis of spontaneous bacterial empyema.  J Clin Gastroenterol. 2005;  39 278-281
  • 62 Sort P, Navasa M, Arroyo V et al.. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.  N Engl J Med. 1999;  341 403-409
  • 63 Castellote J, Ariza J, Girbau A et al.. Risk factors to cefotaxime-resistant spontaneous bacterial peritonitis.  [abstract] J Hepatol. 2010;  52 S69

José Castellote AlonsoM.D. 

Hepatología y Unidad de Trasplante Hepático, Servicio de Aparato Digestivo, Hospital Universitari de Bellvitge, c/Feixa Llarga s/n

08907 L'Hospitalet de Llobregat, Barcelona, Spain

Email: jcastellote@bellvitgehospital.cat

    >